IGC Pharma (IGC) Cash from Investing Activities Growth (5y) (2015 - 2025)
IGC Pharma (IGC) Cash from Investing Activities Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
IGC Pharma |
27.49 Mn |
27.22 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-19.11% |
| Jun 30, 2025 |
20.21% |
| Mar 31, 2025 |
28.14% |
| Dec 31, 2024 |
42.78% |
| Sep 30, 2024 |
41.20% |
| Jun 30, 2024 |
53.74% |
| Mar 31, 2024 |
-8.89% |
| Dec 31, 2023 |
-13.07% |
| Sep 30, 2023 |
61.54% |
| Jun 30, 2023 |
8.97% |
| Mar 31, 2023 |
7.43% |
| Dec 31, 2022 |
35.56% |
| Sep 30, 2022 |
26.68% |
| Jun 30, 2022 |
-110.19% |
| Mar 31, 2022 |
-83.57% |
| Dec 31, 2021 |
15.74% |
| Sep 30, 2021 |
-3.69% |
| Jun 30, 2021 |
4.21% |
| Mar 31, 2021 |
61.03% |
| Dec 31, 2020 |
170.49% |
